down arrow

J B Chemicals &

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE572A01036
  • NSEID: JBCHEPHARM
  • BSEID: 506943
INR
1,572.10
37.1 (2.42%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 62.9 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,538.201,584.00

52 Week

1,303.002,029.00
Valuation
Technical
Day's Volume

CASH

62.9 k (-72.23%) Volume

Shareholding (Dec 2024)

FII

14.64%

Held by 239 FIIs

DII

16.41%

Held by 31 DIIs

Promoter

53.66%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

  • NO KEY NEGATIVE TRIGGERS
2

Stock is technically in a Bearish range

3

With ROE of 19, it has a Very Expensive valuation with a 7.4 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 24,474 Cr (Large Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.99%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

19.03%

stock-summary
Price to Book

7.44

Revenue and Profits (1 Year):
Net Sales:
963 Cr
(Quarterly Results - Dec 2024)
Net Profit:
162 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.99%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-13.28%
0.45%
-12.83%
1 Year
-10.61%
0.81%
-9.8%
2 Years
55.23%
2.88%
58.11%
3 Years
93.7%
5.99%
99.69%
4 Years
150.51%
9.17%
159.68%
5 Years
512.79%
22.03%
534.82%

Latest dividend: 8.5 per share ex-dividend date: Feb-07-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.96%
EBIT Growth (5y)
23.62%
EBIT to Interest (avg)
51.86
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.10
Tax Ratio
25.49%
Dividend Payout Ratio
34.40%
Pledged Shares
0
Institutional Holding
31.05%
ROCE (avg)
28.90%
ROE (avg)
19.37%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
33
Price to Book Value
7.44
EV to EBIT
28.12
EV to EBITDA
23.49
EV to Capital Employed
8.16
EV to Sales
6.15
PEG Ratio
1.56
Dividend Yield
0.99%
ROCE (Latest)
28.21%
ROE (Latest)
19.03%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 29 Schemes (14.57%)

FIIs

Held by 239 FIIs (14.64%)

Promoter with highest holding

Tau Investment Holdings Pte. Ltd. (53.66%)

Highest Public shareholder

Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund (3.16%)

Individual Investors Holdings

13.42%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -3.71% vs -0.38% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -6.92% vs -1.28% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "963.49",
          "val2": "1,000.62",
          "chgp": "-3.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "254.51",
          "val2": "270.52",
          "chgp": "-5.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.58",
          "val2": "2.06",
          "chgp": "25.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "162.49",
          "val2": "174.57",
          "chgp": "-6.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.42%",
          "val2": "27.04%",
          "chgp": "-0.62%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.77% vs 11.52% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 19.97% vs 35.53% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,005.02",
          "val2": "1,777.94",
          "chgp": "12.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "550.89",
          "val2": "475.65",
          "chgp": "15.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.70",
          "val2": "22.43",
          "chgp": "-65.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "351.40",
          "val2": "292.90",
          "chgp": "19.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.48%",
          "val2": "26.75%",
          "chgp": "0.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.20% vs 9.87% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 20.50% vs 32.36% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,968.51",
          "val2": "2,622.45",
          "chgp": "13.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "805.40",
          "val2": "698.77",
          "chgp": "15.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.28",
          "val2": "34.92",
          "chgp": "-70.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "513.89",
          "val2": "426.47",
          "chgp": "20.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.13%",
          "val2": "26.65%",
          "chgp": "0.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.63% vs 29.91% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 34.84% vs 6.35% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,484.18",
          "val2": "3,149.28",
          "chgp": "10.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "896.89",
          "val2": "695.75",
          "chgp": "28.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "44.33",
          "val2": "36.05",
          "chgp": "22.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "552.63",
          "val2": "409.83",
          "chgp": "34.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.74%",
          "val2": "22.09%",
          "chgp": "3.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
963.49
1,000.62
-3.71%
Operating Profit (PBDIT) excl Other Income
254.51
270.52
-5.92%
Interest
2.58
2.06
25.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
162.49
174.57
-6.92%
Operating Profit Margin (Excl OI)
26.42%
27.04%
-0.62%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -3.71% vs -0.38% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -6.92% vs -1.28% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,005.02
1,777.94
12.77%
Operating Profit (PBDIT) excl Other Income
550.89
475.65
15.82%
Interest
7.70
22.43
-65.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
351.40
292.90
19.97%
Operating Profit Margin (Excl OI)
27.48%
26.75%
0.73%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 12.77% vs 11.52% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 19.97% vs 35.53% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,968.51
2,622.45
13.20%
Operating Profit (PBDIT) excl Other Income
805.40
698.77
15.26%
Interest
10.28
34.92
-70.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
513.89
426.47
20.50%
Operating Profit Margin (Excl OI)
27.13%
26.65%
0.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.20% vs 9.87% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 20.50% vs 32.36% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
3,484.18
3,149.28
10.63%
Operating Profit (PBDIT) excl Other Income
896.89
695.75
28.91%
Interest
44.33
36.05
22.97%
Exceptional Items
0.00
0.00
Consolidate Net Profit
552.63
409.83
34.84%
Operating Profit Margin (Excl OI)
25.74%
22.09%
3.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.63% vs 29.91% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 34.84% vs 6.35% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About J B Chemicals & Pharmaceuticals Ltd stock-summary
stock-summary
J B Chemicals & Pharmaceuticals Ltd
Large Cap
Pharmaceuticals & Drugs
J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
Company Coordinates stock-summary
Company Details
Neelam Centre 4th Floor, B-Wing Hind Cycle Road Worli Mumbai Maharashtra : 400030
stock-summary
Tel: 91-022-2482 2222/2493 0918
stock-summary
http://www.jbpharma.com
stock-summary
investorelations@jbcpl.com / secret
Registrar Details
Datamatics Financial Services Ltd , (Formerly Datamatics Financial Services Ltd) , Plot No A / 16 & A / 17, MIDC, Part B, Cross Lane, Marol , Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."